Managing the clinical effects of drug-induced intestinal dysbiosis with a focus to antibiotics: Challenges and opportunities

被引：3

作者：

Gnatzy, Lea ^{[1
]}

Ismailos, George ^{[2
,3
]}

Vertzoni, Maria ^{[1
]}

Reppas, Christos ^{[1
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Dept Pharm, Zografos, Greece

[2] ELPEN Pharmaceut, Expt Res & Training Ctr ELPEN, Pikermi, Greece

[3] Natl Antimicrobial Testing Comm, Athens, Greece

来源：

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2023年 / 188卷

关键词：

Dysbiosis; Intestinal; Drugs; Prevention; Treatment; Microbiota; INTERNATIONAL SCIENTIFIC ASSOCIATION; FECAL MICROBIOTA TRANSPLANTATION; CLOSTRIDIUM-DIFFICILE INFECTION; HUMAN GUT MICROBIOME; BILIARY-EXCRETION; INSULIN SENSITIVITY; CONSENSUS STATEMENT; IRON FORTIFICATION; METABOLIC SYNDROME; PHARMACOKINETICS;

D O I：

10.1016/j.ejps.2023.106510

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The term "intestinal dysbiosis" is used for indicating change(s) of the intestinal microbiota which have been associated with the development of diseases and the deterioration of disease treatments in humans. In this review, documented clinical effects of drug-induced intestinal dysbiosis are briefly presented, and methodologies which could be considered for the management of drug-induced intestinal dysbiosis based on clinical data are critically reviewed. Until relevant methodologies are optimized and/or their effectiveness to the general population is confirmed, and, since drug-induced intestinal dysbiosis refers predominantly to antibiotic-specific intestinal dysbiosis, a pharmacokinetically-based approach for mitigating the impact of antimicrobial therapy on intestinal dysbiosis is proposed.

引用

页数：10

共 50 条

[21] Drug-induced thrombocytopenia: Focus on platelet apoptosis
De Silva, Enoli
Kim, Hugh
CHEMICO-BIOLOGICAL INTERACTIONS, 2018, 284 : 1 - 11
[22] Drug-induced angioedema. Focus on bradykinin
Sachs, B.
Meier, T.
Noethen, M. M.
Stieber, C.
Stingl, J.
HAUTARZT, 2018, 69 (04): : 298 - 305
[23] Drug-Induced Necrotizing Pancreatitis with a Focus on Canagliflozin
Patel, Kinner
Pikas, Eric
George, Tanya
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S557 - S558
[24] A 2015 focus on preventing drug-induced arrhythmias
Bossu, A.
van der Heyden, M. A. G.
de Boer, T. P.
Vos, M. A.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2016, 14 (02) : 245 - 253
[25] A Focus on Drug-Induced Liver Injury Preface
Gholam, Pierre M.
CLINICS IN LIVER DISEASE, 2020, 24 (01) : XIII - XIV
[26] Drug-Induced Hypertension: Focus on Mechanisms and Management
Alexandra R. Lovell
Michael E. Ernst
Current Hypertension Reports, 2017, 19
[27] Drug-induced retinal detachment: focus on cobimetinib
Veremme, L.
Bellet, F.
Rousset, M.
Sassier, M.
Damin-Pernik, M.
Beyens, M. N.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 46 - 46
[28] Drug-Induced Necrotizing Pancreatitis With a Focus on Canagliflozin
Patel, Kinner M.
Pikas, Erik
George, Tanya
AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (04) : E496 - E496
[29] Managing an automated clinical laboratory: optimization challenges and opportunities
Archetti, Claudia
Speranza, M. Grazia
Garrafa, Emirena
EURO JOURNAL ON DECISION PROCESSES, 2020, 8 (1-2) : 41 - 60
[30] CLINICAL ASPECTS OF DRUG-INDUCED BRONCHIAL SIDE-EFFECTS
HUGUES, FC
LEJEUNNE, C
HAAS, C
ANNALES DE MEDECINE INTERNE, 1989, 140 (07): : 585 - 588

← 1 2 3 4 5 →